Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
XBI SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week5.35%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-9.18%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-21.11%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-10.05%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year25.81%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range47.00 - 91.05 Perf YTD6.55%
Dividend0.51 P/FCF- EPS past 5Y- ROI- 52W High-32.68% Beta-
Dividend %0.77% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low30.42% ATR3.69
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)33.46 Volatility6.46% 5.08%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume2.56 Prev Close66.00
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.29M Price61.30
Recom- SMA20-14.64% SMA50-18.73% SMA200-17.87% Volume5,526,281 Change-7.12%
Oct-05-15 11:45AM  Biotechs - Boom, Bust, Now Buy at Forbes
Oct-02-15 04:07PM  XBIs Top Ten Small-Cap Stocks Perform on Par with Large-Caps
04:07PM  ALNY and XON Drag Down Mid-Cap Stocks Last Week
02:53PM  Breaking Down Biotech ETFs With Leverage
Oct-01-15 02:26PM  Biotech: buy the dip?
10:22AM  Biotech: Out of the Ashes at
09:10AM  BioMarin Falls 16.81% in Week Ended September 25
08:55AM  Biotech ETFs Looking Attractive After Sell-Off
07:50AM  China Whacks the Caixin/Markit Survey - Try the Shells in a White Wine, Sausage Cream Sauce
12:06AM  Alkermes and Incyte Outperform in Large-Cap Space
Sep-30-15 11:57PM  Has The Biotech Stock Bubble Popped? at Forbes
02:25PM  XBIs Moving Averages: The Massive Plummet Last Week
02:25PM  Biotech Stocks Hammered Badly Last Week after Clinton Comment
02:09PM  Biotech: Will Valuation End the Carnage? at
07:45AM  Lets Play Dress Up - Try the Risotto di Limone & Gamberi (Lemon Risotto w/Shrimp)
Sep-29-15 02:50PM  Price controls on biotech do not work: Pro
12:09PM  XBIs Top Ten Small-Caps Outperform IBBs Top Ten Small-Caps
Sep-28-15 05:06PM  Opko Health Falls 7.7% in Week Ended September 11 -7.19%
04:55PM  Biotech fund posts worst single-day drop in 4 years at MarketWatch
02:04PM  Step away from biotechs, let dust settle: Pro
01:33PM  Drug Pricing Fears Erase Biotech Stock Gains for the Year at TheStreet
01:03PM  Good-Bye Biotech Bull, Hello Pain at
12:16PM  Ill at Ease with Biotech? Prescribing #1 Healthcare ETFs
11:58AM  Gilead Sciences: 'The Machine Marches Forward' at
11:30AM  Biotech Moves Into A Bear Market And This Record Streak Is About To End
11:05AM  Seattle Genetics: A Performance Overview
10:14AM  XBI Mid-Caps Outperform IBB Mid-Caps
07:30AM  Global Mkts on Sale (Again) - Try the Vellutata di Verdura
Sep-25-15 05:37PM  IBB biotech fund posts largest weekly drop in 7 years at MarketWatch -6.85%
Sep-24-15 01:33PM  Biotech stocks on track for biggest weekly decline in 4 years at MarketWatch
12:07PM  Kite Led Top Ten Stocks by Weight in XBIs Biotechnology Subgroup
12:07PM  Top Ten Stocks of XBI by Weight Outperform
10:39AM  Biotech: Two Charts That Scream Sell at
09:08AM  Advaxis Led the Bottom Ten Biotechnology Stocks by Market Cap
09:07AM  Amicus Drives Small-Cap Stocks
07:52AM  Dont dump biotechnology stocks yet, says chart guru Thomas Dorsey at MarketWatch
Sep-23-15 07:13PM  Biotech ETFs Lose Steam, Extend Week's Losses at Investor's Business Daily
02:53PM  Outrage over high drug costs unlikely to bring change any time soon at MarketWatch
01:52PM  Small-Cap Biotech ETF Rallies Amid Broad Losses at Investor's Business Daily
12:08PM  Seattle Genetics Leads XBI Mid-Cap Stocks
10:48AM  Traders Bet Against Hillary With Leveraged Biotech ETF
09:08AM  XBIs Biotechnology Stocks Rose Week of September 11
07:13AM  Kite Pharma and Juno Therapeutics Led Biotechnology Sector
Sep-22-15 01:55PM  Stocks Extend Sharp Losses on Oil Rout, Fed Hangover at TheStreet
12:59PM  Stocks Extend Losses on Oil Rout, Fed Hangover at TheStreet
12:36PM  Tuesday links: a bull market built on sand
11:13AM  Stocks Extend Losses on Oil Rout at TheStreet
11:06AM  IBB Mid-Cap Outperforms XBI Mid-Cap
10:17AM  Stocks Tank as Crude Oil Plummets at TheStreet
10:07AM  XBI Moving Averages Are on the Rise
09:30AM  The Zacks Analyst Blog Highlights: Twitter, iShares Nasdaq Biotechnology, First Trust NYSE Arca Biotech ETF, PowerShares Dynamic Pharmaceuticals ETF and SPDR S&P Biotech ETF
08:58AM  Stock Futures Tank as China Fears Resurface at TheStreet
08:31AM  What Hillary Clinton and Daraprim Just Did To Biotech Stocks Everywhere
07:31AM  Clinton Drug Plan Cuts Market Exclusivity, Sets Mandatory R&D Spending at TheStreet
06:50AM  [video]Sept. 22 Premarket Briefing: 10 Things You Should Know at TheStreet
Sep-21-15 08:54PM  XBI Rise 6.58% for Week Ended September 11 -5.39%
07:32PM  Thank you Mrs. Clinton for the biotech buying opportunity
06:28PM  Brutal session for biotech, health-care stocks in 3 charts at MarketWatch
03:06PM  US Equities Continue to See Outflows on Slowing Growth
02:24PM  Pill prices & politics
02:06PM  Theravance and Alder Help IBB Small-Caps
01:31PM  Stocks Turn Mixed as Rally Flames Out at TheStreet
01:20PM  The Political Tweet That Thrashed the Biotech Sector at 24/7 Wall St.
12:50PM  Biotech Drug Stocks Tank After Clinton Tweet on Price Controls at TheStreet
Sep-18-15 11:38AM  ETF Winners & Losers Post Dovish Fed Meet
Sep-17-15 07:47PM  Top Ten of XBI Outperform by Market Cap
07:47PM  Performance of XBI and IBB with Respective Benchmark Indexes
12:07PM  Small Caps of IBB Underperform from August 2531
12:07PM  Alnylam and ISIS Lead Mid-Cap Stocks
11:58AM  Even Biotech Bulls Should Be Watching This Level
Sep-16-15 03:40PM  Top Ten XBI Stocks by Market Cap Outperform August 2531
03:39PM  XLV and XBI Outperform Benchmark Indexes from August 2531
03:25PM  1 Smart Way to Play the Biotech Bounce at Motley Fool
11:42AM  The Comprehensive Guide to Biotech ETFs
Sep-15-15 05:15PM  Where's biotech's bubble?
Sep-10-15 11:06PM  Comparing IBBs and XBIs Small-Cap Stocks
Sep-08-15 07:06PM  Opko Health Reports Weak 2Q15 Results
06:49PM  What ETF Investors Can Do When Market Is Volatile at Investor's Business Daily
12:59PM  SPDR S&P Biotech ETF: A Closer Look at Motley Fool
12:08PM  Taking advantage of volatility
Sep-04-15 01:39PM  State Street Splits Coming For Retail, Biotech ETFs at
11:35AM  Incyte Helps XBI to Outperform IBBs Top 10
11:34AM  Benchmark Indexes Continue to Outperform IBB and XBI
Sep-02-15 01:03PM  XBI Pharmaceutical Valuation Rises on Strong Small-Cap Performance
01:02PM  Acadia, Neurocrine, Dyax, and Opko Trade Below 50-Day Moving Average
01:01PM  ICPT and XON Put Pressure on XBIs Biotechnology Sector
11:07AM  Why Did Intrexon Fall by 14.40%?
11:07AM  Analyzing Incyte: What Kind of Company Is It?
Sep-01-15 11:08AM  Incyte Was a Star Performer from August 1017, 2015
09:30AM  State Street Global Advisors Announces ETF Share Splits Business Wire
Aug-31-15 02:33PM  XBI Remains Flat as of August 17, 2015
10:06AM  How Does Novavax Compare to Its Competitors?
09:10AM  4 ETFs That Finished the Wild Week in Green
Aug-25-15 09:17AM  What Are IBB and XBIs Valuations?
Aug-24-15 12:43PM  Biotech Stocks Recover From Early-Morning Flash Crash at TheStreet -5.33%
Aug-21-15 11:08PM  IBB Outperforms XBI: Top 10 Mid-Cap Stocks
Aug-20-15 05:00PM  The Dow's very, very bad day -5.41%
01:52PM  IBB Outperforms XBI: Top 10 Large-Cap Stocks
01:51PM  IBB and XBI Underperformed the Benchmark Indexes
10:53AM  Fear and loathing on trading desks at CNBC
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.